Cisplatin and Probiotic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cisplatin (cisplatin) and Probiotic (bacillus coagulans). Common drug interactions include pneumonia among females and hyponatraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Cisplatin and Probiotic. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Probiotic?

Probiotic has active ingredients of bacillus coagulans. It is often used in irritable bowel syndrome. eHealthMe is studying from 22,462 Probiotic users. Check the latest studies of Probiotic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

13 people who take Cisplatin and Probiotic together, and have interactions are studied.

Cisplatin and Probiotic drug interactions.

What are the common drug interactions of Cisplatin and Probiotic, by gender? *:

female:

  1. Pneumonia
  2. Cardiac tamponade (fluid accumulates in heart covering)
  3. Liver injury
  4. Pericardial effusion (fluid around the heart)
  5. Alopecia (absence of hair from areas of the body)
  6. Neuropathy peripheral (surface nerve damage)

male:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Dehydration (dryness resulting from the removal of water)
  3. Cardiac failure congestive
  4. Cough
  5. Disease progression
  6. Dyspnoea (difficult or laboured respiration)
  7. Heart rate increased
  8. Hyperhidrosis (abnormally increased sweating)
  9. Hypoxia (low oxygen in tissues)
  10. Increased upper airway secretion

What are the common drug interactions of Cisplatin and Probiotic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Neuropathy peripheral (surface nerve damage)

50-59:

  1. Prostate cancer
  2. Cough
  3. Disease progression
  4. Dyspnoea (difficult or laboured respiration)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypoxia (low oxygen in tissues)
  7. Increased upper airway secretion
  8. Pleural effusion (water on the lungs)
  9. Rales (an abnormal respiratory sound characterized by fine crackles)
  10. Rhonchi (abnormal breath sounds)

60+:

  1. Pneumonia
  2. Cardiac tamponade (fluid accumulates in heart covering)
  3. Liver injury
  4. Pericardial effusion (fluid around the heart)
  5. Anaemia (lack of blood)
  6. Cardiac failure congestive
  7. Heart rate increased
  8. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 3 people, 23.08%
  2. Metastatic Neoplasm (spreadable cancer tumour): 3 people, 23.08%
  3. Breakthrough Pain: 3 people, 23.08%
  4. Constipation: 3 people, 23.08%
  5. Diabetes: 3 people, 23.08%
  6. Diarrhea: 3 people, 23.08%
  7. High Blood Pressure: 3 people, 23.08%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 23.08%
  9. Hypotension (abnormally low blood pressure): 3 people, 23.08%
  10. Acute Kidney Failure: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and Probiotic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cisplatin and Probiotic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Probiotic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cisplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Probiotic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cisplatin and bacillus coagulans (the active ingredients of Cisplatin and Probiotic, respectively), and Cisplatin and Probiotic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: